89bio (ETNB) Short Interest Ratio & Short Volume → Warren Buffett's 'mystery stock' (From Stansberry Research) (Ad) Free ETNB Stock Alerts $8.99 +0.36 (+4.17%) (As of 03:26 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media 89bio Short Interest DataCurrent Short Volume10,750,000 sharesPrevious Short Volume11,210,000 sharesChange Vs. Previous Month-4.10%Dollar Volume Sold Short$91.48 millionShort Interest Ratio / Days to Cover9.4Last Record DateApril 30, 2024Outstanding Shares98,384,000 sharesPercentage of Shares Shorted10.93%Today's Trading Volume270,825 sharesAverage Trading Volume1,127,555 sharesToday's Volume Vs. Average24% Short Selling 89bio ? Sign up to receive the latest short interest report for 89bio and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatETNB Short Interest Over TimeETNB Days to Cover Over TimeETNB Percentage of Float Shorted Over Time Ad Crypto 101 MediaThe Overlooked Retirement Asset You Probably Don’t Own4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm.Click here to access the Crypto Retirement Blueprint now. 89bio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202410,750,000 shares $91.48 million -4.1%N/A9.4 $8.51 4/15/202411,210,000 shares $106.38 million -2.9%N/A8.9 $9.49 3/31/202411,550,000 shares $134.44 million +4.0%N/A8.8 $11.64 3/15/202411,110,000 shares $150.21 million +2.3%N/A8.2 $13.52 2/29/202410,860,000 shares $124.56 million +2.7%N/A7.6 $11.47 2/15/202410,580,000 shares $103.58 million +9.9%N/A7.8 $9.79 Get the Latest News and Ratings for ETNB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for 89bio and its competitors with MarketBeat's FREE daily newsletter. 1/31/20249,630,000 shares $95.34 million +7.2%N/A7.1 $9.90 1/15/20248,980,000 shares $99.59 million +5.9%N/A6.7 $11.09 12/31/20238,480,000 shares $94.72 million +24.5%N/A4.9 $11.17 12/15/20236,810,000 shares $72.19 million +12.0%N/A3.9 $10.60 11/30/20236,080,000 shares $48.88 million +0.7%N/A3.6 $8.04 11/15/20236,040,000 shares $45.96 million +11.2%N/A3.9 $7.61 10/31/20235,430,000 shares $40.18 million -19.1%N/A3.7 $7.40 10/15/20236,710,000 shares $51.13 million +6.0%N/A4.7 $7.62 9/30/20236,330,000 shares $97.74 million +7.5%N/A5.6 $15.44 9/15/20235,890,000 shares $102.25 million -6.4%N/A5.7 $17.36 8/31/20236,290,000 shares $107.81 million -28.4%N/A5.3 $17.14 8/15/20238,780,000 shares $147.07 million +9.5%N/A6.9 $16.75 7/31/20238,020,000 shares $127.04 million -11.2%N/A6 $15.84 7/15/20239,030,000 shares $164.80 million -5.0%N/A6.7 $18.25 6/30/20239,500,000 shares $180.03 million +36.5%N/A6.6 $18.95 6/15/20236,960,000 shares $144.00 million -2.3%N/A4 $20.69 5/31/20237,120,000 shares $129.80 million -1.4%N/A3.2 $18.23 5/15/20237,220,000 shares $129.02 million -4.4%N/A3.3 $17.87 4/30/20237,550,000 shares $120.65 million -1.2%N/A3.4 $15.98 4/15/20237,640,000 shares $118.57 million -5.1%N/A3.5 $15.52 3/31/20238,050,000 shares $122.60 million +44.0%N/A3.9 $15.23 3/15/20235,590,000 shares $71.50 million +8.5%N/A2.9 $12.79 2/28/20235,150,000 shares $70.14 million +10.8%N/A4.8 $13.62 2/15/20234,650,000 shares $60.45 million No ChangeN/A4.5 $13.00 1/31/20234,650,000 shares $54.31 million +8.6%N/A4.8 $11.68 1/15/20234,280,000 shares $44.94 million -3.4%N/A4.8 $10.50 12/30/20224,430,000 shares $56.39 million -7.1%N/A4.9 $12.73 12/15/20224,770,000 shares $49.37 million +30.3%N/A5.3 $10.35 11/30/20223,660,000 shares $29.28 million No ChangeN/A2.7 $8.00 11/15/20223,660,000 shares $35.83 million -0.3%N/A2.8 $9.79 10/31/20223,670,000 shares $35.05 million -3.2%N/A2.8 $9.55 10/15/20223,790,000 shares $29.07 million +28.0%N/A3 $7.67 9/30/20222,960,000 shares $17.14 million -6.0%N/A2.6 $5.79 9/15/20223,150,000 shares $18.43 million +55.2%N/A2.7 $5.85Warren Buffett's "mystery stock" (Ad)WARNING: Read This Before the Next Fed Meeting Investors are looking to the Fed with high hopes for interest rate relief. Unfortunately, many have no idea there's another major story unfolding right now, one that could be worth $40 trillion. This Wall Street millionaire just stepped forward with all the details, and how it could make some ETNB Short Interest - Frequently Asked Questions What is 89bio's current short interest? Short interest is the volume of 89bio shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 10,750,000 shares of ETNB short. Learn More on 89bio's current short interest. What is a good short interest ratio for 89bio? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ETNB shares currently have a short interest ratio of 9.0. Learn More on 89bio's short interest ratio. Which institutional investors are shorting 89bio? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of 89bio: PEAK6 Investments LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is 89bio's short interest increasing or decreasing? 89bio saw a decline in short interest in the month of April. As of April 30th, there was short interest totaling 10,750,000 shares, a decline of 4.1% from the previous total of 11,210,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does 89bio's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to 89bio: Immunome, Inc. (4.42%), OPKO Health, Inc. (26.42%), Centessa Pharmaceuticals plc (2.99%), ABIVAX Société Anonyme (0.12%), ARS Pharmaceuticals, Inc. (15.81%), Liquidia Co. (10.62%), Pliant Therapeutics, Inc. (12.51%), Ocular Therapeutix, Inc. (13.61%), Arcutis Biotherapeutics, Inc. (18.74%), Zentalis Pharmaceuticals, Inc. (24.64%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short 89bio stock? Short selling ETNB is an investing strategy that aims to generate trading profit from 89bio as its price is falling. ETNB shares are trading up $0.36 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against 89bio? A short squeeze for 89bio occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ETNB, which in turn drives the price of the stock up even further. How often is 89bio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ETNB, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Immunome Short Interest OPKO Health Short Interest Centessa Pharmaceuticals Short Interest ABIVAX Société Anonyme Short Interest ARS Pharmaceuticals Short Interest Liquidia Short Interest Pliant Therapeutics Short Interest Ocular Therapeutix Short Interest Arcutis Biotherapeutics Short Interest Zentalis Pharmaceuticals Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ETNB) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressDoes this make you sick?Allegiance GoldThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldUrgent Nvidia WarningAltimetryThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge Alerts